Legend Biotech (LEGN) Current Assets (2019 - 2024)
Legend Biotech (LEGN) has disclosed Current Assets for 6 consecutive years, with $1.3 billion as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Current Assets fell 14.28% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2024, down 14.28%, and an annual FY2024 reading of $1.3 billion, down 14.28% over the prior year.
- Current Assets was $1.3 billion for Q4 2024 at Legend Biotech, down from $1.5 billion in the prior quarter.
- Across five years, Current Assets topped out at $1.5 billion in Q4 2023 and bottomed at $593.9 million in Q4 2020.
- Average Current Assets over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
- The sharpest move saw Current Assets soared 186.79% in 2020, then decreased 14.28% in 2024.
- Year by year, Current Assets stood at $593.9 million in 2020, then surged by 59.92% to $949.8 million in 2021, then rose by 15.72% to $1.1 billion in 2022, then soared by 36.27% to $1.5 billion in 2023, then dropped by 14.28% to $1.3 billion in 2024.
- Business Quant data shows Current Assets for LEGN at $1.3 billion in Q4 2024, $1.5 billion in Q4 2023, and $1.1 billion in Q4 2022.